About
Epitomee Medical is a public company focused on developing and commercializing innovative ingestible therapeutic devices for targeted therapies in the gastrointestinal (GI) tract. Their core product platform features swallowable capsules designed to deliver therapies precisely in specific areas of the stomach, duodenum, and small intestine. These capsules enable mechanosensory stimulation, targeted drug delivery, and absorption management, dissolving naturally after use. The company's technology is adaptable for various applications, including weight management, biologics delivery, and chronic disease management. Epitomee Medical collaborates with multinational industry leaders to advance new applications that align with strategic needs, aiming to enhance patient outcomes. The leadership team includes Dr. Dan Hashimshony, who has a strong background in biomedical engineering, and Yael, who specializes in clinical and regulatory affairs.
Technologies
Keywords
Company Information
- Employees42
- Founded2005
- Total Funding$1895000000
Location
Tarshish Industrial Park Street, Caesarea, Haifa District, Israel
